Recent developments in radiotherapy for small-cell lung cancer: a review by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
Clin. transl. oncol. (Print)
; 19(10): 1183-1192, oct. 2017. tab
Artigo
em Inglês
| IBECS
| ID: ibc-166150
Biblioteca responsável:
ES1.1
Localização: BNCS
ABSTRACT
Small-cell lung cancer (SCLC) accounts for 13% of all lung tumours. The standard treatment in patients with limited-stage disease is radiotherapy combined with chemotherapy. In extensive SCLC, the importance of consolidation thoracic radiotherapy in patients with a good treatment response has become increasingly recognized. In both limited and extensive disease, prophylactic cranial irradiation is recommended in patients who respond to treatment. New therapeutic approaches such as immunotherapy are being increasingly incorporated into the treatment of SCLC, although more slowly than in non-small cell lung cancer (NSCLC). Diverse radiation dose and fractionation schemes, administered in varying combinations with these new drugs, are being investigated. In the present study we review and update the role of radiotherapy in the treatment of SCLC. We also discuss the main clinical trials currently underway in order to identify future trends (AU)
RESUMEN
No disponible
Buscar no Google
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Irradiação Craniana
/
Carcinoma de Pequenas Células do Pulmão
/
Imunoterapia
Tipo de estudo:
Estudo prognóstico
Limite:
Humanos
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2017
Tipo de documento:
Artigo
Instituição/País de afiliação:
Complejo Hospitalario de Navarra/Spain
/
Hospital Ruber Internacional/Spain
/
Hospital Universitario Quirón Madrid/Spain
/
Hospital Universitario Ramón y Cajal/Spain
/
Hospital Universitario Santiago de Compostela/Spain
/
Parc de Salut MAR/Spain